Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 3/10/2026India Still Relies Heavily on China for Essential Pharmaceutical Ingre...
  • 3/10/2026Ascletis Reports Positive Phase 2 Results for Monthly ASC30 Obesity Th...
  • 3/10/2026CSPC Subsidiary Registers Phase I/II Trial for In Vivo CD19 CAR-T Ther...
  • 3/10/2026Laekna and Eli Lilly Complete Phase 1 Study of ActRIIA Antibody LAE102...
  • 3/10/2026Junshi Secures NMPA Acceptance for Subcutaneous Toripalimab Across 12 ...
  • 3/10/2026China Patent Expiry and New GLP-1 Drugs Spark Global Obesity Drug Comp...
  • 3/10/2026Hutchmed Withdraws Tazverik from China Following Safety Concerns
  • 3/10/2026China's Average Life Expectancy Hits 79.25 Years in 2025: NHC
  • 3/9/2026China Publishes 102nd Batch of Reference Formulations for Generics and...
  • 3/9/2026NMPA Seeks Input on Draft Guidelines for Quality Summaries of Therapeu...
  • 3/9/2026Biocytogen Achieves Key Clinical Milestone as IDEAYA Initiates Phase I...
  • 3/9/2026Regeneron Highlights Positive Chinese Phase III Data for Obesity Candi...
  • 3/9/2026Kelun Biotech and Harbour BioMed's SKB575 Receives IND Clearance in Ch...
  • 3/9/2026Rapport Licenses Seizure Drug Candidate to Tenacia in Greater China
  • 3/9/2026iCamuno Biothera Raises Over CNY 100M in Series A3 to Advance iPSC Cel...
  • 3/9/2026Hansoh's B7-H3 ADC Shows Promising Lung Cancer Activity in Cancer Cell...
  • 3/9/2026Hansoh Reports Positive Phase 3 Results for Weekly GLP-1/GIP Dual Agon...
  • 3/9/2026Merck KGaA Drops Hengrui-Licensed PARP1 Candidate After Early Clinical...
  • 3/9/2026Abbisko's Pimicotinib Phase 3 MANEUVER Results Published in The Lancet
  • 3/6/2026Recent Executive Moves
  • 3/6/2026China Approves Novo's Weekly Insulin–GLP-1 Combination Therapy for Ty...
  • 3/6/2026Abbisko Doses First Patient in Trial of KRAS G12D Inhibitor ABSK141
  • 3/6/2026Lynk's Zemprocitinib Meets Phase III Endpoints in Atopic Dermatitis
  • 3/6/2026Sciwind's Ecnoglutide Approved in China for Obesity
  • 3/5/2026CMS Wins China Trial Approval for INHBE-Targeting Obesity siRNA Drug
  • 3/5/2026CDE Issues Guidance on Subject Selection for Oncology Drug Bioequivale...
  • 3/4/2026CSPC's Emicizumab Injection Receives Clinical Trial Approval in China
  • 3/4/2026CDE Invites Feedback on Draft Technical Guideline for Preventive mRNA ...
  • 3/4/2026CDE Issues Technical Guideline on Clinical Trials for Drugs Treating C...
  • 3/4/2026Leman Biotech Raises ~CNY 200M to Advance Metabolism-Enhanced CAR-T Pl...
  • Page:9/62 Total number of articles:1850: [First][<<] [7] [8] [9] [10] [11] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group